Artal Group as of Dec. 31, 2018
Portfolio Holdings for Artal Group
Artal Group holds 94 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Weight Watchers International | 21.2 | $571M | 15M | 38.55 | |
Lexicon Pharmaceuticals (LXRX) | 14.8 | $400M | 60M | 6.64 | |
General Motors Company (GM) | 4.3 | $117M | 3.5M | 33.45 | |
Beigene (BGNE) | 4.2 | $112M | 800k | 140.26 | |
Bank of America Corporation (BAC) | 4.1 | $111M | 4.5M | 24.64 | |
Moderna (MRNA) | 3.0 | $80M | 5.3M | 15.27 | |
Wells Fargo & Company (WFC) | 2.6 | $69M | 1.5M | 46.08 | |
Celgene Corporation | 2.4 | $64M | 1.0M | 64.09 | |
Morgan Stanley (MS) | 2.2 | $60M | 1.5M | 39.65 | |
Alnylam Pharmaceuticals (ALNY) | 2.2 | $58M | 800k | 72.91 | |
Alibaba Group Holding (BABA) | 2.1 | $57M | 412k | 137.07 | |
Acceleron Pharma | 2.0 | $54M | 1.3M | 43.55 | |
Scholar Rock Hldg Corp (SRRK) | 1.9 | $53M | 2.3M | 22.97 | |
Rubius Therapeutics | 1.7 | $47M | 2.9M | 16.08 | |
Nio Inc spon ads (NIO) | 1.6 | $42M | 6.6M | 6.37 | |
Goldman Sachs (GS) | 1.6 | $42M | 250k | 167.05 | |
Array BioPharma | 1.3 | $36M | 2.5M | 14.25 | |
Atara Biotherapeutics (ATRA) | 1.3 | $35M | 1.0M | 34.74 | |
Amicus Therapeutics (FOLD) | 1.2 | $34M | 3.5M | 9.58 | |
Nektar Therapeutics (NKTR) | 1.2 | $33M | 1.0M | 32.87 | |
Blueprint Medicines (BPMC) | 1.2 | $32M | 600k | 53.91 | |
Bristol Myers Squibb (BMY) | 1.1 | $29M | 550k | 51.98 | |
Agios Pharmaceuticals (AGIO) | 1.0 | $28M | 600k | 46.11 | |
Fate Therapeutics (FATE) | 1.0 | $28M | 2.2M | 12.83 | |
Bluebird Bio (BLUE) | 1.0 | $27M | 275k | 99.20 | |
Argenx Se (ARGX) | 1.0 | $26M | 270k | 96.07 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.8 | $22M | 1.4M | 15.78 | |
Fibrogen (FGEN) | 0.8 | $21M | 450k | 46.28 | |
Freeport-McMoRan Copper & Gold (FCX) | 0.8 | $21M | 2.0M | 10.31 | |
Medicines Company | 0.7 | $19M | 1.0M | 19.14 | |
Xencor (XNCR) | 0.7 | $18M | 500k | 36.16 | |
Inflarx Nv (IFRX) | 0.7 | $18M | 500k | 36.37 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $17M | 200k | 85.15 | |
Autolus Therapeutics Plc spon ads (AUTL) | 0.6 | $16M | 475k | 32.84 | |
Solid Biosciences | 0.5 | $13M | 500k | 26.80 | |
Micron Technology (MU) | 0.5 | $13M | 400k | 31.73 | |
Audentes Therapeutics | 0.5 | $13M | 600k | 21.32 | |
Albireo Pharma | 0.5 | $12M | 500k | 24.53 | |
Allogene Therapeutics (ALLO) | 0.4 | $11M | 400k | 26.93 | |
Denali Therapeutics (DNLI) | 0.4 | $10M | 500k | 20.66 | |
Wynn Resorts (WYNN) | 0.4 | $9.9M | 100k | 98.91 | |
Clementia | 0.4 | $10M | 850k | 11.76 | |
American Airls (AAL) | 0.4 | $9.6M | 300k | 32.11 | |
Sage Therapeutics (SAGE) | 0.3 | $9.6M | 100k | 95.79 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $9.6M | 150k | 63.79 | |
Melco Crown Entertainment (MLCO) | 0.3 | $8.8M | 500k | 17.62 | |
Madrigal Pharmaceuticals (MDGL) | 0.3 | $7.9M | 70k | 112.71 | |
Vici Pptys (VICI) | 0.3 | $7.5M | 400k | 18.78 | |
Zogenix | 0.3 | $7.3M | 200k | 36.46 | |
Regenxbio Inc equity us cm (RGNX) | 0.3 | $7.1M | 170k | 41.95 | |
Ac Immune Sa (ACIU) | 0.3 | $7.1M | 750k | 9.45 | |
Vale (VALE) | 0.2 | $6.6M | 500k | 13.19 | |
Agenus (AGEN) | 0.2 | $6.5M | 2.8M | 2.38 | |
Rocket Pharmaceuticals (RCKT) | 0.2 | $5.9M | 400k | 14.82 | |
Crinetics Pharmaceuticals In (CRNX) | 0.2 | $6.0M | 200k | 29.99 | |
Accelr8 Technology | 0.2 | $5.8M | 500k | 11.50 | |
Dicerna Pharmaceuticals | 0.2 | $5.6M | 525k | 10.69 | |
Krystal Biotech (KRYS) | 0.2 | $5.7M | 275k | 20.78 | |
Sangamo Biosciences (SGMO) | 0.2 | $4.6M | 400k | 11.48 | |
Translate Bio | 0.2 | $4.5M | 600k | 7.50 | |
Replimune Group (REPL) | 0.2 | $4.5M | 450k | 10.00 | |
Iovance Biotherapeutics (IOVA) | 0.2 | $4.4M | 500k | 8.85 | |
Cymabay Therapeutics (CBAY) | 0.1 | $3.9M | 500k | 7.87 | |
Crispr Therapeutics (CRSP) | 0.1 | $4.1M | 145k | 28.57 | |
D Stemline Therapeutics | 0.1 | $3.8M | 400k | 9.50 | |
Spero Therapeutics (SPRO) | 0.1 | $3.7M | 600k | 6.15 | |
Clovis Oncology | 0.1 | $3.6M | 200k | 17.96 | |
Zafgen | 0.1 | $3.5M | 700k | 4.95 | |
Restorbio | 0.1 | $3.4M | 400k | 8.62 | |
Twist Bioscience Corp (TWST) | 0.1 | $3.5M | 150k | 23.09 | |
Zillow Group Inc Cl C Cap Stk (Z) | 0.1 | $3.2M | 100k | 31.58 | |
Arcus Biosciences Incorporated (RCUS) | 0.1 | $3.2M | 300k | 10.77 | |
Merus N V (MRUS) | 0.1 | $2.9M | 206k | 14.00 | |
Tricida | 0.1 | $2.9M | 125k | 23.58 | |
Gritstone Oncology Ord (GRTS) | 0.1 | $3.1M | 200k | 15.45 | |
Chimerix (CMRX) | 0.1 | $2.6M | 1.0M | 2.57 | |
Akebia Therapeutics (AKBA) | 0.1 | $2.6M | 475k | 5.53 | |
Aduro Biotech | 0.1 | $2.6M | 1.0M | 2.64 | |
Aerpio Pharmaceuticals | 0.1 | $2.6M | 1.6M | 1.70 | |
111 Inc ads (YI) | 0.1 | $2.8M | 450k | 6.14 | |
Momenta Pharmaceuticals | 0.1 | $2.2M | 200k | 11.04 | |
Alder Biopharmaceuticals | 0.1 | $2.1M | 200k | 10.25 | |
Cytomx Therapeutics (CTMX) | 0.1 | $2.3M | 150k | 15.10 | |
Homology Medicines (FIXX) | 0.1 | $2.2M | 100k | 22.36 | |
Tg Therapeutics (TGTX) | 0.1 | $1.6M | 400k | 4.10 | |
Selecta Biosciences (RNAC) | 0.1 | $1.6M | 600k | 2.66 | |
Miragen Therapeutics | 0.1 | $1.5M | 500k | 3.03 | |
Avrobio Ord (AVRO) | 0.1 | $1.7M | 100k | 16.65 | |
Marinus Pharmaceuticals | 0.1 | $1.4M | 500k | 2.87 | |
Ironwood Pharmaceuticals (IRWD) | 0.0 | $1.1M | 111k | 10.36 | |
Magenta Therapeutics | 0.0 | $1.1M | 200k | 5.70 | |
Y Mabs Therapeutics (YMAB) | 0.0 | $1.0M | 50k | 20.34 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $257k | 150k | 1.71 | |
Noveliontherapeuti.. | 0.0 | $215k | 256k | 0.84 |